| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.31▼ | 8.33▼ | 8.35▼ | 8.39▼ | 8.71▼ |
| MA10 | 8.37▼ | 8.32▼ | 8.26▲ | 8.60▼ | 9.06▼ |
| MA20 | 8.27▲ | 8.30▼ | 8.36▼ | 8.96▼ | 9.13▼ |
| MA50 | 8.39▼ | 8.42▼ | 8.66▼ | 9.15▼ | 8.89▼ |
| MA100 | 8.64▼ | 8.87▼ | 9.00▼ | 9.21▼ | 9.51▼ |
| MA200 | 8.99▼ | 8.92▼ | 9.04▼ | 7.72▲ | 21.66▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.022▲ | 0.025▲ | -0.089▼ | -0.131▼ |
| RSI | 46.567▼ | 47.329▼ | 45.673▼ | 42.273▼ | 46.207▼ |
| STOCH | 13.356▼ | 61.063 | 70.125 | 25.400 | 30.162 |
| WILL %R | -94.545▼ | -35.616 | -50.526 | -74.935 | -84.837▼ |
| CCI | -79.611 | 25.357 | -5.188 | -69.971 | -118.955▼ |
|
Friday, May 22, 2026 11:42 AM
ATRA Deadline: Rosen Law Firm Urges Atara Biotherapeutics, Inc. (NASDAQ: ATRA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights Rosen Law Firm, a ...
|
|
Thursday, May 07, 2026 08:19 AM
Atara Biotherapeutics said the FDA outlined a potential pathway for resubmitting the tabelecleucel application after a recent Complete Response Letter. ・Atara Biotherapeutics (NASDAQ:ATRA) said the ...
|
|
Wednesday, March 25, 2026 05:00 PM
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA) investors concerning the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/11/26 | 8.41 | 8.495 | 8.27 | 8.27 | 14,559 |
| 02/11/26 | 8.05 | 8.59 | 8.02 | 8.48 | 31,595 |
| 30/10/26 | 8.53 | 8.53 | 7.7231 | 8.01 | 29,930 |
| 29/10/26 | 8.73 | 8.84 | 8.2602 | 8.53 | 11,853 |
| 28/10/26 | 8.25 | 8.66 | 8.2201 | 8.66 | 26,853 |
| 27/10/26 | 8.44 | 8.57 | 8.14 | 8.30 | 21,396 |
| 26/10/26 | 8.68 | 8.68 | 8.10 | 8.35 | 35,268 |
| 23/10/26 | 9.37 | 9.37 | 8.55 | 8.59 | 24,319 |
| 22/10/26 | 9.23 | 9.65 | 8.9709 | 9.43 | 23,018 |
| 21/10/26 | 9.25 | 9.43 | 9.17 | 9.35 | 26,542 |
|
|
||||
|
|
||||
|
|